Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Eagle Pharmaceuticals, Inc. to Present at September Investor Conferences
-
Eagle Pharmaceuticals, Inc. Reports Second Quarter 2017 Results
-
Eagle Pharmaceuticals (EGRX) PT Trimmed to $92 at Cantor Fitzgerald; Angiomax Announcement Removes Overhang
-
Eagle Pharmaceuticals to Present at Cantor Fitzgerald Inaugural Healthcare Conference
-
Eagle Pharmaceuticals (EGRX) PT Raised to $95 at Cantor Fitzgerald
-
UPDATE: Eagle Pharmaceuticals (EGRX) PT Raised to $65 at Cantor Fitzgerald
-
Eagle Pharmaceuticals (EGRX) PT Raised to $51 at Cantor Fitzgerald
-
Eagle Pharmaceuticals (EGRX) 1.3M Offering Priced at $42/Share
-
Eagle Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Eagle Pharmaceuticals (EGRX) Commences $50M Stock Offering
-
Eagle Pharmaceuticals Announces Commencement of Public Offering of Common Stock
-
Unusual 11 Mid-Day Movers 2/18: (CAPN) (ANGI) (MSN) Higher; (VRNS) (ROSG) (FOSL) Lower
-
Cantor Fitzgerald Starts Eagle Pharmaceuticals (EGRX) at Buy
-
Eagle Pharmaceuticals (EGRX) IPO Opens Higher

